Circ MedTech

Circ MedTech

enables safe simple and scalable adult male circumcision

Human health & social work | South Africa | Disease Specific Prevention and Mitigation |

 

Overview

Circ MedTech (CIRC) has developed the PrePex device a device that enables safe simple and scalable adult male circumcision (MC) programs. MC is an effective proven method of reducing lifetime risk of HIV infection by approximately 60% in high risk areas such as Sub Saharan Africa. While traditional methods of circumcision require skilled medical professionals and surgery type settings and equipment the PrePex device offers a safe way to scale up non surgical male circumcision to help the region achieve its HIV prevention goals. The first country to officially approve the PrePex device for routine use is Rwanda with a national goal to decrease the HIV incidence rate by 50% by launching a voluntary MC program to reach 2 million men in 2 years.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Other Legal Structure Operating 11 - 50 employees

Funding and Financing Rounds


Team


Impact

Geographies:

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters


Johannesburg, South Africa



Explore

Revision History

Last Update: Dec 08, 2017 9:54 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2018 IMPACTSPACE. ALL RIGHTS RESERVED.